Skip to content

Antibiotic THErapy iN vIral Airway iNfections (ATHENIAN): An open labelled randomized controlled pragmatic trial to evaluate the efficacy and safety of discontinuing antibiotic therapy in adult patients infected with respiratory viruses

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-509286-20-00
Enrollment
400
Registered
2024-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Viral respiratory tract infection

Brief summary

Early clinical response assessed at 120 hours after randomization, defined as survival with symptom improvement without receipt of rescue antibacterial therapy

Detailed description

In-hospital mortality, Mortality at 30 days, Duration of hospital admission, Days of therapy with antibiotics, Rescue antibiotic therapy during hospital admission, New antibiotic therapy for presumed airway infection up to 30 days after discharge, Hospital readmissions up to 30 days after discharge

Interventions

DRUG-

Sponsors

Akershus University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Early clinical response assessed at 120 hours after randomization, defined as survival with symptom improvement without receipt of rescue antibacterial therapy

Secondary

MeasureTime frame
In-hospital mortality, Mortality at 30 days, Duration of hospital admission, Days of therapy with antibiotics, Rescue antibiotic therapy during hospital admission, New antibiotic therapy for presumed airway infection up to 30 days after discharge, Hospital readmissions up to 30 days after discharge

Countries

Norway

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026